Skip to main navigation

1. Top-bar nav

Investor Presentation

7. Mobile nav

Home
Operating Units
News
Team
Investors
Franchising
Contact Us

2. Main nav

Home
Operating Units
News
Team
Investors
Franchising
Contact Us

News

News

News Category

Year

5/22/2020

XpresSpa Signs Contract with JFK International Air Terminal LLC for COVID-19 Screening and Testing Location

4/13/2020

XpresSpa Appoints Doctor Lewis Lipsey as First Chief Medical Director for Its XpresTest Subsidiary

4/7/2020

XpresSpa Appoints Michael Lebowitz to Board of Directors

4/6/2020

XpresSpa Group Announces Pricing of $3.05 Million Registered Direct Offering Priced At-The-Market

4/3/2020

UPDATE - XpresSpa Pursues Novel Coronavirus (COVID-19) Screening and Testing at U.S. Airports

4/3/2020

XpresSpa Pursues Novel Coronavirus (COVID-19) Screening and Testing at U.S. Airports

3/27/2020

XpresSpa Group Announces Pricing of $2,000,000 Registered Direct Offering Priced At-The-Market

3/25/2020

XpresSpa Group Announces Pricing of $1,790,000 Registered Direct Offering Priced At-The-Market

3/25/2020

XpresSpa Announces Partnership with Relevant Healthcare

3/19/2020

XpresSpa seeks to support COVID-19 testing in 46 locations across 23 US Airports

Pagination

Current page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
Next page

XpresSpa Group © 2020. All Rights Reserved.

6. Footer nav

Privacy Policy | Terms of Use | Careers

NASDAQ SYMBOL:

Price | Change